MedTrace Logo

Prospective Evaluation of Long-term Outcomes After Pulmonary Embolism

NCT01174628 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2014-11-26

No results posted yet for this study

Summary

The purpose of this study is to evaluate the long-term impact of Pulmonary Embolism (PE) on heart and lung function, quality of life, ability to work, symptoms of breathlessness and functional status of patients one year after their initial diagnosis and treatment for PE

Conditions

Sponsors & Collaborators

  • Sir Mortimer B. Davis - Jewish General Hospital

    lead OTHER

Principal Investigators

  • Susan R Kahn, M.D., M.Sc. · Sir Mortimer B. Davis - Jewish General Hospital

  • Andrew Hirsch, M.D. · Sir Mortimer B. Davis - Jewish General Hospital

  • John Granton, M.D. · University of Toronto

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2014-12-31
Completion
2015-02-28

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01174628 on ClinicalTrials.gov